NewsRoom Articles
Lexaria Bioscience Corp. (NASDAQ: LEXX) Marks GLP-1 Study Milestone with Ethics Review Board Approval
Lexaria, a global innovator in drug delivery platforms, has received approval for its GLP-1 human pilot study #2 by an…
Software Effective Solutions Corp. (SFWJ) Subsidiary Inks Major Deal with Danziger Colombia
New three-year agreement between SFWJ’s Eko2o and Danziger Colombia reflects both companies’ commitment to sustainable, innovative agriculture practices The collaboration…
Lexaria Bioscience Corp. (NASDAQ: LEXX) Grows Global Patent Portfolio to 41; Maintains Focus on GLP-1 Clinical Studies for 2024
Lexaria, a global innovator in drug delivery platforms, has added three new patents to its portfolio, bringing the total to…
Golden Triangle Ventures Inc. (GTVH) Announces CEO Interview Series, Partners with Consulting Company on Flagship Destino Ranch Project
CEO interview series provides Golden Triangle with a platform to share its story with an expanded audience Collaboration with Cayenne…
Lexaria Bioscience Corp. (NASDAQ: LEXX) Bolsters C-Suite with New CFO Appointment
Lexaria, a global innovator in drug delivery platforms, has announced the appointment of Nelson Cabatuan, CPA, as its new CFO…
Golden Triangle Ventures Inc. (GTVH) Making Key Progress in Development of Destino Ranch, an Immersive Entertainment Venue
Developed under Lavish Entertainment, a wholly owned subsidiary of GTVH, Destino Ranch will be a one-of-a-kind destination that revolutionizes the…
Lexaria Bioscience Corp. (NASDAQ: LEXX) Hires Contract Research Organization to Perform Important GLP-1 Human Pilot Study
Lexaria, a global innovator in drug delivery platforms, recently hired a Contract Research Organization to perform their second GLP-1 human…
Software Effective Solutions Corp. (SFWJ) Completes Key Acquisitions, Is Committed to Becoming Cannabis Market Leader
MedCana adds to portfolio with strategic acquisition of two cannabis companies First acquisition represents “leap forward” in SFWJ’s commitment to…
Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM)-CBD Achieves 7% Weight Loss; Sets Stage for 8-week Diabetes and Weight Loss Animal Study
Lexaria, a global innovator in drug delivery platforms, highlighted results from its DIAB-A22-1 animal study, highlighting a 7% reduction in…
Lexaria Bioscience Corp. (NASDAQ: LEXX) Marks Huge 2024 Milestone with FDA Clearance for its Planned U.S. Phase 1b Hypertension Clinical Trial
Lexaria, a global innovator in drug delivery platforms, recently received FDA clearance for its HYPER-H23-1 clinical study John Docherty, President…